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Volume 59, Number 1 Abstracts 273Good Clinical Outcome After Accidental Intra-arterial Injection of
FlunitrazepamTablets in 16DrugAbusers withCritical Limb Ischaemia
Rohm S., Staab H., Schulz H., Richter O., Aust G. Eur J Vasc Endovasc
Surg 2014;47:61-7.
Objectives: Inadvertent intra-arterial injection of ﬂunitrazepam tab-
lets intended for intravenous use by drug abusers has devastating effects.
We report here on the clinical outcome of 16 drug abusers developing crit-
ical limb ischaemia after ﬂunitrazepam injection.
Methods: Treatment combined immediate analgesia and anticoagula-
tion, long-lasting local thrombolysis and vasodilatation, antibiotic prophy-
laxis, and physical mobilization. The immediate bolus injection of 5,000
IU heparin was followed by a continuous heparin infusion up to the target
partial thromboplastin time. Under arteriographic control local intra-arterial
infusion with alternating 4-h cycles of 5 mg recombinant tissue plasminogen
activator followed by 5 mg prostaglandinE1 (PGE1) was performed for
24-48 hours. Subsequently, 60 mg PGE1 was applied once daily.
Results: Drug abusers, having been injected with 4-30 mg ﬂunitraze-
pam, were treated 3-72 hours after the accident, with six of them not being
treated until after 24 hours. All showed a high tissue ischaemia score. At the
time of being discharged from hospital 13 patients had a normal extremity.
In one patient, ﬁrst receiving treatment 72 hours after injection, minor
amputation of ﬁngers was necessary. The life of the patient who injected
30 mg ﬂunitrazepam in the leg was saved after hip disarticulation. One pa-
tient developed neurological dysfunction in the affected toes.
Conclusions: Intensive treatment after inadvertent intra-arterial drug
injection normalized the affected extremity in most drug abusers, even after
the late onset of therapy.
Quantifying the Degree Graduated Elastic Compression Stockings
Enhance Venous Emptying
Lattimer C.R., Kalodiki E., Kafeza M., Azzam M., Geroulakos G. Eur J
Vasc Endovasc Surg 2014;47;75-80.Objectives: Graduated elastic compression (GEC) stockings reduce
reﬂux and venous volume but their performance on augmenting venous re-
turn is unproven. The aim of this study was to quantify the ability of stock-
ings to increase venous outﬂow from the leg.
Design: A prospective study comparing venous emptying without
compression, versus class 1 (18-21 mmHg) and class 2 (23-32 mmHg)
compression, using air-plethysmography (APG).
Methods: The right legs of 20 healthy subjects were studied su-
pine. A 12-cm thigh-cuff was inﬂated in 10 mmHg steps from 0 to
80 mmHg while the corresponding increase in calf volume was recorded
using the APG sensor calf-cuff. At the 80 mmHg plateau, the thigh-cuff
was released suddenly to measure the unrestricted venous emptying.
Venous return was assessed by: (a) identifying the incremental thigh-
cuff pressure causing the maximal incremental increase in calf volume
(IPMIV); (b) measuring the percentage reduction in calf volume in
1 second following thigh-cuff release e outﬂow fraction (OF); (c)
time to empty 90% of the venous volume e venous emptying time
(VET90).
Results: Median and inter-quartile range (IQR) baseline values of
IPMIV, OF, and VET90 without compression were 20 mmHg (range,
20-30 mmHg), 44% (39-50%) and 13 seconds (8.8-15.9 seconds),
respectively. These improved signiﬁcantly with all stockings. The applica-
tion of any stocking raised the median IPMIV by 30 mmHg. The
change from a class 2 stocking compared with no stocking versus the
change from a class 1 stocking to no stocking had a more pronounced
effect (P < .005). After sudden thigh-cuff deﬂation, the venous emptying
was 41-45% greater and 9-10 seconds faster with all stockings
(P < .005).
Conclusions: This is the ﬁrst study to quantify the venous return
of below-knee GEC stockings. Assessments of stockings in augment-
ing venous return may be of use as a way of optimising com-
pression for individual patients unresponsive to standard conservative
treatment.
